Free Trial

Jayne Cottam Buys 348 Shares of Assura Plc (LON:AGR) Stock

Assura logo with Real Estate background

Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam acquired 348 shares of the firm's stock in a transaction on Monday, April 7th. The shares were acquired at an average price of GBX 43 ($0.56) per share, with a total value of £149.64 ($195.86).

Jayne Cottam also recently made the following trade(s):

  • On Wednesday, March 5th, Jayne Cottam acquired 363 shares of Assura stock. The shares were bought at an average price of GBX 41 ($0.54) per share, for a total transaction of £148.83 ($194.80).
  • On Wednesday, February 5th, Jayne Cottam purchased 405 shares of Assura stock. The shares were bought at an average cost of GBX 37 ($0.48) per share, for a total transaction of £149.85 ($196.14).

Assura Stock Down 0.1 %

LON:AGR traded down GBX 0.05 ($0.00) during trading hours on Friday, hitting GBX 47.69 ($0.62). The stock had a trading volume of 19,406,164 shares, compared to its average volume of 31,666,986. The company has a market cap of £1.55 billion, a PE ratio of -45.59, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The business has a 50 day simple moving average of GBX 43.85 and a two-hundred day simple moving average of GBX 40.71. Assura Plc has a 1-year low of GBX 35.24 ($0.46) and a 1-year high of GBX 48.86 ($0.64). The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

Recommended Stories

Insider Buying and Selling by Quarter for Assura (LON:AGR)

Should You Invest $1,000 in Assura Right Now?

Before you consider Assura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.

While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines